Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HIVEP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MRPL35 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEP68 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FMR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TNFRSF10B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2Q1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NFKBIE - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DLAT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MYLIP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SVIP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WRN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LSM5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPRIN3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ESR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STXBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DYRK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POMZP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CHAMP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DPY19L3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on